History
  • No items yet
midpage
James Kerrigan v. Otsuka America Pharmaceutical
706 F. App'x 769
| 3rd Cir. | 2017
Read the full case

Background

  • Kerrigan was Senior Director of Global Marketing at Otsuka America (OAPI), responsible for Samsca branding and ensuring promotional materials underwent mandatory Promotional Review Committee (PRC) review.
  • In Feb 2011, an article about Samsca was posted without PRC review or proper disclosures; legal instructed removal and Kerrigan recommended contacting the FDA; OAPI later self-reported to the FDA.
  • In June 2011, Kerrigan reported a second Samsca compliance problem; OAPI self-reported and sent corrective communications to over 20,000 people; Kerrigan was not disciplined for these incidents.
  • In 2012, OAPI gave Kerrigan a “Needs Improvement” review, denied a raise, and reduced his bonus due to concerns about multiple compliance investigations tied to his team and his leadership.
  • In May 2012, an investigation disclosed Kerrigan had helped his wife’s consulting firm secure a contract with an affiliate, violating OAPI’s code of conduct; OAPI terminated Kerrigan immediately.
  • Kerrigan sued under New Jersey’s CEPA claiming the negative review, reduced compensation, and termination were retaliation for his reports; the District Court granted summary judgment for OAPI, and Kerrigan appealed.

Issues

Issue Plaintiff's Argument Defendant's Argument Held
Whether Kerrigan established causation for CEPA retaliation Kerrigan argued his reports of Samsca violations prompted adverse actions (review, pay cut, firing) OAPI/Altmeyer argued adverse actions resulted from legitimate performance and ethics concerns, not retaliation Affirmed for defendants — no evidence of causation
Whether temporal proximity supports an inference of retaliation Kerrigan relied on timing between reports (2011) and adverse actions (2012) Defendants argued the gaps (6–12 months) are not "unusually suggestive" and insufficient alone Temporal gap insufficient; timing does not establish causation
Whether direct or circumstantial evidence shows retaliatory animus Kerrigan pointed to alleged increased criticism by Altmeyer after reports Altmeyer provided an unrebutted declaration that criticism stemmed from leadership/conduct concerns Court found no admissible evidence rebutting defendant’s explanation; no factual nexus shown
Whether a reasonable jury could find retaliatory discrimination was a determinative factor Kerrigan argued adverse actions were likely motivated by retaliation Defendants asserted legitimate, nonretaliatory reasons (compliance costs, leadership failures, ethics violation) No — reasonable jury could not find retaliation was more likely than not a determinative factor

Key Cases Cited

  • Carvalho-Grevious v. Del. State Univ., 851 F.3d 249 (3d Cir. 2017) (standard of review for summary judgment)
  • Farrell v. Planters Lifesavers Co., 206 F.3d 271 (3d Cir. 2000) (temporal proximity and causation analysis)
  • LeBoon v. Lancaster Jewish Cmty. Cntr. Ass’n, 503 F.3d 217 (3d Cir. 2007) (temporal proximity insufficient to infer causation)
  • Lichtenstein v. Univ. of Pittsburgh Med. Ctr., 691 F.3d 294 (3d Cir. 2012) (short temporal proximity can be sufficient)
  • Battaglia v. United Parcel Serv., Inc., 214 N.J. 518 (N.J. 2013) (circumstantial evidence framework for retaliation claims)
  • Lippman v. Ethicon, Inc., 222 N.J. 362 (N.J. 2015) (CEPA retaliation requires causation)
Read the full case

Case Details

Case Name: James Kerrigan v. Otsuka America Pharmaceutical
Court Name: Court of Appeals for the Third Circuit
Date Published: Sep 1, 2017
Citation: 706 F. App'x 769
Docket Number: 16-3218
Court Abbreviation: 3rd Cir.